Biofrontera Reports Beat in Q4 GAAP EPS But Revenue Falls Short by $1.21M
Monday, 18 March 2024, 04:39
Biofrontera Quarterly Results Analysis
Biofrontera released its Q4 financial results, reporting a GAAP EPS of $1.65 which exceeded expectations by $2.79. However, the revenue stood at $10.6M, reflecting a 5.0% Y/Y increase, but still missing estimates by $1.21M. The Adjusted EBITDA for the quarter was recorded as negative $3.2.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.